{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T05:02:58Z","timestamp":1793854978149,"version":"4.6.1"},"reference-count":266,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:00:00Z","timestamp":1675296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Cannabidiol (CBD) has numerous pharmacological targets that initiate anti-inflammatory, antioxidative, and antiepileptic properties. These neuroprotective benefits have generated interest in CBD's therapeutic potential against the secondary injury cascade from traumatic brain injury (TBI). There are currently no effective broad treatment strategies for combating the damaging mechanisms that follow the primary injury and lead to lasting neurological consequences or death. However, CBD's effects on different neurotransmitter systems, the blood brain barrier, oxidative stress mechanisms, and the inflammatory response provides mechanistic support for CBD's clinical utility in TBI. This review describes the cascades of damage caused by TBI and CBD's neuroprotective mechanisms to counter them. We also present challenges in the clinical treatment of TBI and discuss important future clinical research directions for integrating CBD in treatment protocols. The mechanistic evidence provided by pre-clinical research shows great potential for CBD as a much-needed improvement in the clinical treatment of TBI. Upcoming clinical trials sponsored by major professional sport leagues are the first attempts to test the efficacy of CBD in head injury treatment protocols and highlight the need for further clinical research.<\/jats:p>","DOI":"10.3389\/fneur.2023.1087011","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T06:23:15Z","timestamp":1675318995000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":43,"title":["Cannabidiol's neuroprotective properties and potential treatment of traumatic brain injuries"],"prefix":"10.3389","volume":"14","author":[{"given":"Mackenzie M.","family":"Aychman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Goldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua S.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.3171\/2017.10.JNS17352","article-title":"Estimating the global incidence of traumatic brain injury","volume":"130","author":"Dewan","year":"2018","journal-title":"J Neurosurg."},{"key":"B2","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S1474-4422(18)30415-0","article-title":"Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990-2016: a systematic analysis for the global burden of disease study 2016","volume":"18","author":"James","year":"2019","journal-title":"Lancet Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/00001199-200609000-00001","article-title":"The epidemiology and impact of traumatic brain injury: a brief overview","volume":"21","author":"Langlois","year":"2006","journal-title":"J Head Trauma Rehabil."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/acprof:oso\/9780195179484.001.0001","author":"Finkelstein","year":"2006","journal-title":"The Incidence and Economic Burden of Injuries in the United States."},{"key":"B5","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1017\/cjn.2016.290","article-title":"The international incidence of traumatic brain injury: a systematic review and meta-analysis","volume":"43","author":"Nguyen","year":"2016","journal-title":"Can J Neurol Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/nrneurol.2013.38","article-title":"Giving voice to a silent epidemic","volume":"9","author":"Rusnak","year":"2013","journal-title":"Nat Rev Neurol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.brainres.2009.06.067","article-title":"Severity of controlled cortical impact traumatic brain injury in rats and mice dictates degree of behavioral deficits","volume":"1287","author":"Yu","year":"2009","journal-title":"Brain Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1089\/neu.2013.3019","article-title":"Pharmacotherapy of traumatic brain injury: state of the science and the road forward: report of the department of defense neurotrauma pharmacology workgroup","volume":"31","author":"Diaz-Arrastia","year":"2014","journal-title":"J Neurotrauma."},{"key":"B9","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1124\/jpet.121.001023","article-title":"Targets of neuroprotection and review of pharmacological interventions in traumatic brain injury","volume":"382","author":"Hiskens","year":"2022","journal-title":"J Pharmacol Exp Ther."},{"key":"B10","doi-asserted-by":"publisher","first-page":"12131","DOI":"10.1021\/acs.jmedchem.0c00095","article-title":"Synthetic access to cannabidiol and analogs as active pharmaceutical ingredients","volume":"63","author":"Pirrung","year":"2020","journal-title":"J Med Chem."},{"key":"B11","doi-asserted-by":"publisher","first-page":"113844","DOI":"10.1016\/j.expneurol.2021.113844","article-title":"Cannabidiol reduces lesion volume and restores vestibulomotor and cognitive function following moderately severe traumatic brain injury","volume":"346","author":"Friedman","year":"2021","journal-title":"Exp Neurol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.3390\/pharmaceutics14081609","article-title":"Cannabidiol reduces short- and long-term high glutamate release after severe traumatic brain injury and improves functional recovery","volume":"14","author":"Santiago-Casta\u00f1eda","year":"2022","journal-title":"Pharm."},{"key":"B13","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3389\/fphar.2019.00352","article-title":"Oral cannabidiol prevents allodynia and neurological dysfunctions in a mouse model of mild traumatic brain injury","volume":"10","author":"Belardo","year":"2019","journal-title":"Front Pharmacol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s13311-015-0377-3","article-title":"Molecular targets of cannabidiol in neurological disorders","volume":"12","author":"Ibeas Bih","year":"2015","journal-title":"Neurotherapeutics."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e10003524","DOI":"10.1371\/journal.pmed.1003524","article-title":"Safety and tolerability of natural and synthetic cannabinoids in adults aged over 50 years: a systematic review and meta-analysis","volume":"18","author":"Velayudhan","year":"2021","journal-title":"PLoS Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s43856-022-00202-8","article-title":"Clinical and cognitive improvement following full-spectrum, high-cannabidiol treatment for anxiety: open-label data from a two-stage, phase 2 clinical trial","volume":"2","author":"Dahlgren","year":"2022","journal-title":"Commun Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"129","DOI":"10.14740\/jocmr4090","article-title":"Dosage, efficacy and safety of cannabidiol administration in adults: a systematic review of human trials","volume":"12","author":"Larsen","year":"2020","journal-title":"J Clin Med Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.2174\/1570159X15666170613083606","article-title":"Recent advances in pathophysiology of traumatic brain injury","volume":"16","author":"Kaur","year":"2018","journal-title":"Curr Neuropharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.csm.2010.09.001","article-title":"The molecular pathophysiology of concussive brain injury","volume":"30","author":"Barkhoudarian","year":"2011","journal-title":"Clin Sports Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1080\/02699052.2017.1312528","article-title":"Brain injury injury cascades in TBI-related neurodegeneration injury cascades in TBI-related neurodegeneration","volume":"31","author":"Dekosky","year":"2017","journal-title":"Brain Inj"},{"key":"B21","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s10571-016-0400-1","article-title":"Pathophysiology associated with traumatic brain injury: current treatments and potential novel therapeutics","volume":"37","author":"Pearn","year":"2017","journal-title":"Cell Mol Neurobiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.brainres.2014.10.030","article-title":"White matter integrity and cognition in mild traumatic brain injury following motor vehicle accident","volume":"1591","author":"Xiong","year":"2014","journal-title":"Brain Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/jnr.24331","article-title":"Neuroinflammation and blood\u2013brain barrier disruption following traumatic brain injury: pathophysiology and potential therapeutic targets","volume":"98","author":"Sulhan","year":"2020","journal-title":"J Neurosci Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11910-015-0545-1","article-title":"Glutamate and GABA imbalance following traumatic brain injury","volume":"15","author":"Guerriero","year":"2015","journal-title":"Curr Neurol Neurosci Rep."},{"key":"B25","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1038\/s41380-018-0239-6","article-title":"Neurotransmitter changes after traumatic brain injury: an update for new treatment strategies","volume":"24","author":"McGuire","year":"2018","journal-title":"Mol Psychiatry."},{"key":"B26","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/nrneurol.2017.13","article-title":"The far-reaching scope of neuroinflammation after traumatic brain injury","volume":"13","author":"Simon","year":"2017","journal-title":"Nat Rev Neurol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1002\/ana.1230","article-title":"Long-term hyperexcitability in the hippocampus after experimental head trauma","volume":"50","author":"Santhakumar","year":"2001","journal-title":"Ann Neurol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.exer.2019.03.013","article-title":"Amelioration of visual deficits and visual system pathology after mild TBI with the cannabinoid type-2 receptor inverse agonist SMM-189","volume":"182","author":"Guley","year":"2019","journal-title":"Exp Eye Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1002\/eji.201243084","article-title":"Traumatic brain injury induces macrophage subsets in the brain","volume":"43","author":"Hsieh","year":"2013","journal-title":"Eur J Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"689","DOI":"10.2174\/1871527317666180627120501","article-title":"Oxidative stress: major threat in traumatic brain injury","volume":"17","author":"Khatri","year":"2018","journal-title":"CNS Neurol Disord Drug Targets."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1089\/neu.2019.6963","article-title":"Systemic inflammation persists the first year after mild traumatic brain injury: results from the prospective trondheim mild traumatic brain injury study","volume":"37","author":"Chaban","year":"2020","journal-title":"J Neurotrauma."},{"key":"B32","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/bph.13179","article-title":"Progressive inflammation-mediated neurodegeneration after traumatic brain or spinal cord injury","volume":"173","author":"Faden","year":"2016","journal-title":"Br J Pharmacol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3389\/fimmu.2018.00672","article-title":"The inflammatory continuum of traumatic brain injury and Alzheimer's disease","volume":"9","author":"Kokiko-Cochran","year":"2018","journal-title":"Front Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3389\/fnagi.2017.00208","article-title":"Microglial activation in traumatic brain injury","volume":"9","author":"Donat","year":"2017","journal-title":"Front Aging Neurosci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1089\/neu.1997.14.715","article-title":"Progressive atrophy and neuron death for one year following brain trauma in the rat","volume":"14","author":"Smith","year":"1997","journal-title":"J Neurotrauma."},{"key":"B36","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0300-483X(97)03654-8","article-title":"Visual system degeneration induced by blast overpressure","volume":"121","author":"Petras","year":"1997","journal-title":"Toxicology."},{"key":"B37","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1097\/NEN.0b013e31821f891f","article-title":"Repetitive closed-skull traumatic brain injury in mice causes persistent multifocal axonal injury and microglial reactivity","volume":"70","author":"Shitaka","year":"2011","journal-title":"J Neuropathol Exp Neurol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/B978-0-444-52892-6.00004-0","article-title":"The neuropathology of traumatic brain injury","volume":"127","author":"Mckee","year":"2015","journal-title":"Handb Clin Neurol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3390\/jcm10010148","article-title":"Clinical medicine assessing the severity of traumatic brain injury-time for a change?","volume":"10","author":"Tenovuo","year":"2021","journal-title":"J Clin Med."},{"key":"B40","author":"Cifu","year":"2016","journal-title":"VA\/DoD Clinical Practice Guideline For The Management Of Concussion-Mild Traumatic Brain Injury The Management of Concussion-mild Traumatic Brain Injury Working Group"},{"key":"B41","author":"Gerberding","year":"2003","journal-title":"Report to Congress on Mild Traumatic Brain Injury in the United States: Steps to Prevent a Serious Public Health Problem"},{"key":"B42","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1080\/16501970510027321","article-title":"Summary of the WHO collaborating centre for neurotrauma task force on mild traumatic brain injury","volume":"37","author":"Holm","year":"2005","journal-title":"J Rehabil Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1097\/00005373-200104000-00032","article-title":"Minor head injury: 13 is an unlucky number","volume":"50","author":"Stein","year":"2001","journal-title":"J Trauma."},{"key":"B44","author":"Rajajee","year":"2022","journal-title":"Management of Acute Moderate and Severe Traumatic Brain Injury\u2014UpToDate"},{"key":"B45","first-page":"1","article-title":"Multidisciplinary postacute rehabilitation for moderate to severe traumatic brain injury in adults","author":"Brasure","year":"2012","journal-title":"Comp Eff Rev."},{"key":"B46","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.apmr.2021.02.003","article-title":"Expert panel survey to update the american congress of rehabilitation medicine definition of mild traumatic brain injury","volume":"102","author":"Silverberg","year":"2021","journal-title":"Arch Phys Med Rehabil."},{"key":"B47","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1046\/j.1468-1331.2002.00407.x","article-title":"EFNS guideline on mild traumatic brain injury: report of an EFNS task force","volume":"9","author":"Vos","year":"2002","journal-title":"Eur J Neurol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1080\/16501960410023732","article-title":"Incidence, risk factors and prevention of mild traumatic brain injury: results of the WHO collaborating centre task force on mild traumatic brain injury","volume":"36","author":"Cassidy","year":"2004","journal-title":"J Rehabil Med."},{"key":"B49","year":"","journal-title":"Concussion, Traumatic Brain Injury, CDC Injury Center"},{"key":"B50","author":"Evans","year":"2021","journal-title":"Acute Mild Traumatic Brain Injury (Concussion) in Adults."},{"key":"B51","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/00129492-200403000-00009","article-title":"Characterizing and treating dizziness after mild head trauma","volume":"25","author":"Hoffer","year":"2004","journal-title":"Otol Neurotol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1080\/02699052.2017.1357834","article-title":"Recovery progression and symptom resolution in sport-related mild traumatic brain injury","volume":"31","author":"Abbassi","year":"2017","journal-title":"Brain Inj."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1111\/trf.15171","article-title":"Management of moderate and severe traumatic brain injury","volume":"59","author":"Abdelmalik","year":"2019","journal-title":"Transfusion."},{"key":"B54","first-page":"60","article-title":"Decompressive craniectomy and traumatic brain injury: a review","volume":"1","author":"Alvis-Miranda","year":"2013","journal-title":"Bull Emerg Trauma."},{"key":"B55","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1017\/cjn.2020.23","article-title":"Neuroprotection following concussion: the potential role for cannabidiol","volume":"47","author":"Singh","year":"2020","journal-title":"Can J Neurol Sci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"147586","DOI":"10.1016\/j.brainres.2021.147586","article-title":"Effects of cannabinoid (CBD) on blood brain barrier permeability after brain injury in rats","volume":"1768","author":"Jiang","year":"2021","journal-title":"Brain Res."},{"key":"B57","doi-asserted-by":"publisher","first-page":"11286","DOI":"10.1038\/s41598-022-15134-5","article-title":"Effects of chronic cannabidiol in a mouse model of naturally occurring neuroinflammation, neurodegeneration, and spontaneous seizures","volume":"12","author":"Dearborn","year":"2022","journal-title":"Sci Rep."},{"key":"B58","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/sj.npp.1300340","article-title":"Effects of cannabidiol (CBD) on regional cerebral blood flow","volume":"29","author":"Alexandre De Souza Crippa","year":"2004","journal-title":"Neuropsychopharmacology."},{"key":"B59","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/epi.14629","article-title":"Cannabidiol reduces seizures and associated behavioral comorbidities in a range of animal seizure and epilepsy models","volume":"60","author":"Patra","year":"2019","journal-title":"Epilepsia."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1017\/S1461145712001502","article-title":"The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system","volume":"16","author":"Campos","year":"2013","journal-title":"Int J Neuropsychopharmacol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/jcbfm.1993.22","article-title":"Regional changes in interstitial K+ and Ca2+ levels following cortical compression contusion trauma in rats","volume":"13","author":"Nilsson","year":"1993","journal-title":"J Cereb Blood Flow Metab."},{"key":"B62","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/0006-8993(93)90064-T","article-title":"Concussive brain injury is associated with a prolonged accumulation of calcium: a45Ca autoradiographic study","volume":"624","author":"Fineman","year":"1993","journal-title":"Brain Res."},{"key":"B63","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3389\/fphar.2012.00060","article-title":"Altered calcium signaling following traumatic brain injury","volume":"3","author":"Weber","year":"2012","journal-title":"Front Pharmacol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0379-0738(02)00344-4","article-title":"The expression of excitatory amino acid transporter 2 in traumatic brain injury","volume":"130","author":"Ikematsu","year":"2002","journal-title":"Forensic Sci Int."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1089\/neu.2006.23.1518","article-title":"Decreased expression of glutamate transporters in astrocytes after human traumatic brain injury","volume":"23","author":"Van Landeghem","year":"2006","journal-title":"J Neurotrauma."},{"key":"B66","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1111\/j.1471-4159.1993.tb07437.x","article-title":"Traumatic brain injury-induced excitotoxicity assessed in a controlled cortical impact model","volume":"61","author":"Palmer","year":"1993","journal-title":"J Neurochem."},{"key":"B67","doi-asserted-by":"publisher","first-page":"528","DOI":"10.3389\/fncel.2019.00528","article-title":"Traumatic brain injuries: pathophysiology and potential therapeutic targets","volume":"13","author":"Ng","year":"2019","journal-title":"Front Cell Neurosci."},{"key":"B68","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3389\/fnins.2016.00449","article-title":"mild traumatic brain injury produces neuron loss that can be rescued by modulating microglial activation using a cb2 receptor inverse agonist","volume":"10","author":"Bu","year":"2016","journal-title":"Front Neurosci."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1089\/neu.2008.0532","article-title":"Calcium-permeable AMPA receptors appear in cortical neurons after traumatic mechanical injury and contribute to neuronal fate","volume":"25","author":"Spaethling","year":"2008","journal-title":"J Neurotrauma."},{"key":"B70","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nn835","article-title":"Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways","volume":"5","author":"Hardingham","year":"2002","journal-title":"Nat Neurosci."},{"key":"B71","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1162\/neco_a_01343","article-title":"Nmda receptor alterations after mild traumatic brain injury induce deficits in memory acquisition and recall","volume":"33","author":"Schumm","year":"2021","journal-title":"Neural Comput."},{"key":"B72","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1089\/neu.2012.2483","article-title":"GABAA receptor regulation after experimental traumatic brain injury","volume":"29","author":"Raible","year":"2012","journal-title":"J Neurotrauma."},{"key":"B73","doi-asserted-by":"publisher","first-page":"ra9","DOI":"10.1126\/scisignal.1162396","article-title":"BDNF selectively regulates GABAA receptor transcription by activation of the JAK\/STAT pathway","volume":"1","author":"Lund","year":"2008","journal-title":"Sci Signal."},{"key":"B74","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.expneurol.2015.07.001","article-title":"JAK\/STAT pathway regulation of GABAA receptor expression after differing severities of experimental TBI","volume":"271","author":"Raible","year":"2015","journal-title":"Exp Neurol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"29431","DOI":"10.1074\/jbc.C600167200","volume":"281","author":"Roberts","year":"2006","journal-title":"J Biol Chem."},{"key":"B76","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1093\/cercor\/bhr096","article-title":"Altered bidirectional plasticity and reduced implicit motor learning in concussed athletes","volume":"22","author":"De Beaumont","year":"2012","journal-title":"Cereb Cortex."},{"key":"B77","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/0006-8993(88)90034-0","article-title":"The effect of concussive head injury on central cholinergic neurons","volume":"452","author":"Saija","year":"1988","journal-title":"Brain Res."},{"key":"B78","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1080\/01616412.2015.1110402","article-title":"Traumatic brain injury decreases serotonin transporter expression in the rat cerebrum","volume":"38","author":"Abe","year":"2016","journal-title":"Neurol Res."},{"key":"B79","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/0304-3940(95)11979-7","article-title":"Basal and scopolamine-evoked release of hippocampal acetylcholine following traumatic brain injury in rats","volume":"198","author":"Dixon","year":"1995","journal-title":"Neurosci Lett."},{"key":"B80","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/0006-8993(94)91879-1","article-title":"Muscarinic cholinergic receptor binding in rat brain following traumatic brain injury","volume":"640","author":"Lyeth","year":"1994","journal-title":"Brain Res."},{"key":"B81","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1089\/neu.1996.13.457","article-title":"Effects of traumatic brain injury on the cholinergic system in the rat","volume":"13","author":"Gorman","year":"2009","journal-title":"J Neurotrauma."},{"key":"B82","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.neubiorev.2017.07.009","article-title":"Dual-transmitter systems regulating arousal, attention, learning and memory","volume":"85","author":"Ma","year":"2018","journal-title":"Neurosci Biobehav Rev."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1089\/neu.2015.4252","article-title":"Prevalence of and risk factors for anxiety and depressive disorders after traumatic brain injury: a systematic review","volume":"33","author":"Scholten","year":"2016","journal-title":"J Neurotrauma."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1089\/neu.2006.23.1094","article-title":"Enhanced catecholamine synthesis in the prefrontal cortex after traumatic brain injury: implications for prefrontal dysfunction","volume":"23","author":"Kobori","year":"2006","journal-title":"J Neurotrauma."},{"key":"B85","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.neulet.2016.04.009","article-title":"Epigenetic changes following traumatic brain injury and their implications for outcome, recovery and therapy","volume":"625","author":"Wong","year":"2016","journal-title":"Neurosci Lett."},{"key":"B86","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1093\/brain\/aww128","article-title":"Catecholamines and cognition after traumatic brain injury","volume":"139","author":"Jenkins","year":"2016","journal-title":"Brain."},{"key":"B87","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.brainres.2010.10.096","article-title":"Traumatic brain injury reduces striatal tyrosine hydroxylase activity and potassium-evoked dopamine release in rats","volume":"1369","author":"Shin","year":"2011","journal-title":"Brain Res."},{"key":"B88","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1179\/016164103101201094","article-title":"The morphological and neurochemical effects of diffuse brain injury on rat central noradrenergic system","volume":"25","author":"Fujinaka","year":"2013","journal-title":"Neurol Res."},{"key":"B89","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/msj.20098","article-title":"Blast-related mild traumatic brain injury: mechanisms of injury and impact on clinical care","volume":"76","author":"Elder","year":"2009","journal-title":"Mt Sinai J Med A J Transl Pers Med."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1177\/0963689717714105","article-title":"Impact of traumatic brain injury on dopaminergic transmission","volume":"26","author":"Chen","year":"2017","journal-title":"Cell Transplant."},{"key":"B91","doi-asserted-by":"publisher","first-page":"987","DOI":"10.3389\/fimmu.2021.663102","article-title":"Immunomodulatory effects of dopamine in inflammatory diseases","volume":"12","author":"Feng","year":"2021","journal-title":"Front Immunol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1097\/00003246-199108000-00010","article-title":"Thermogenic and metabolic effects of dopamine in healthy men","volume":"19","author":"Ruttimann","year":"1991","journal-title":"Crit Care Med."},{"key":"B93","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1097\/WNR.0b013e32832a0a98","article-title":"Dopamine D1-like receptor activation induces brain-derived neurotrophic factor protein expression","volume":"20","author":"Williams","year":"2009","journal-title":"Neuroreport."},{"key":"B94","doi-asserted-by":"publisher","first-page":"3582","DOI":"10.3390\/ijms22073582","article-title":"The role of bdnf in experimental and clinical traumatic brain injury","volume":"22","author":"Gustafsson","year":"2021","journal-title":"Int J Mol Sci."},{"key":"B95","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1177\/1545968315586465","article-title":"Brain-derived neurotrophic factor (BDNF) in traumatic brain injury-related mortality: interrelationships between genetics and acute systemic and central nervous system BDNF profiles","volume":"30","author":"Failla","year":"2016","journal-title":"Neurorehabil Neural Repair."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1089\/neu.2014.3445","article-title":"Alterations in cholinergic pathways and therapeutic strategies targeting cholinergic system after traumatic brain injury","volume":"32","author":"Shin","year":"2015","journal-title":"J Neurotrauma."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1080\/02699052.2016.1219058","article-title":"Progression of tau pathology within cholinergic nucleus basalis neurons in chronic traumatic encephalopathy: a chronic effects of neurotrauma consortium study","volume":"30","author":"Mufson","year":"2016","journal-title":"Brain Inj."},{"key":"B98","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1097\/00005053-199005000-00002","article-title":"Frontal lobe dysfunction following closed head injury. A review of the literature","volume":"178","author":"Mattson","year":"1990","journal-title":"J Nerv Ment Dis."},{"key":"B99","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1089\/neu.2016.4452","article-title":"Inhibition of endocannabinoid degradation improves outcomes from mild traumatic brain injury: a mechanistic role for synaptic hyperexcitability","volume":"34","author":"Mayeux","year":"2017","journal-title":"J Neurotrauma."},{"key":"B100","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1096\/fasebj.2018.32.1_supplement.877.5","article-title":"Inhibition of endocannabinoid degradation improves behavioral effects of traumatic brain injury that are associated with amygdalar hyperexcitability in rats","volume":"32","author":"Fucich","year":"2018","journal-title":"FASEB J."},{"key":"B101","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1089\/neu.2014.3508","article-title":"Endocannabinoid degradation inhibition improves neurobehavioral function, blood-brain barrier integrity, and neuroinflammation following mild traumatic brain injury","volume":"32","author":"Katz","year":"2014","journal-title":"J Neurotrauma."},{"key":"B102","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1097\/MCO.0000000000000027","article-title":"The endocannabinoid system: an emerging key player in inflammation","volume":"17","author":"Witkamp","year":"2014","journal-title":"Curr Opin Clin Nutr Metab Care."},{"key":"B103","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1365-2826.2008.01671.x","article-title":"Cannabinoid receptors: where they are and what they do","volume":"20","author":"Mackie","year":"2008","journal-title":"J Neuroendocrinol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"4929","DOI":"10.4049\/jimmunol.1201777","article-title":"Cannabinoid 1 receptors in keratinocytes modulate proinflammatory chemokine secretion and attenuate contact allergic inflammation","volume":"190","author":"Gaffal","year":"2013","journal-title":"J Immunol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3389\/fncel.2016.00294","article-title":"Cannabinoid receptors in the central nervous system: their signaling and roles in disease","volume":"10","author":"Kendall","year":"2017","journal-title":"Front Cell Neurosci."},{"key":"B106","doi-asserted-by":"publisher","first-page":"108287","DOI":"10.1016\/j.neuropharm.2020.108287","article-title":"Differential glutamatergic and GABAergic contributions to the tetrad effects of \u03949-tetrahydrocannabinol revealed by cell-type-specific reconstitution of the CB1 receptor","volume":"179","author":"De Giacomo","year":"2020","journal-title":"Neuropharmacology."},{"key":"B107","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1038\/npp.2012.123","article-title":"Biphasic effects of cannabinoids in anxiety responses: CB1 and GABAB receptors in the balance of GABAergic and glutamatergic neurotransmission","volume":"37","author":"Rey","year":"2012","journal-title":"Neuropsychopharmacology."},{"key":"B108","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/cercor\/bhj133","article-title":"Differential effects of endocannabinoids on glutamatergic and GABAergic inputs to layer 5 pyramidal neurons","volume":"17","author":"Fortin","year":"2007","journal-title":"Cereb Cortex."},{"key":"B109","doi-asserted-by":"publisher","first-page":"4449","DOI":"10.1007\/s00018-016-2300-4","article-title":"The CB2 receptor and its role as a regulator of inflammation","volume":"73","author":"Turcotte","year":"2016","journal-title":"Cell Mol Life Sci."},{"key":"B110","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/sj.bjp.0707584","article-title":"CB2 receptors in the brain: role in central immune function","volume":"153","author":"Cabral","year":"2008","journal-title":"Br J Pharmacol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.bbi.2017.10.021","article-title":"Selective activation of cannabinoid receptor-2 reduces neuroinflammation after traumatic brain injury via alternative macrophage polarization","volume":"68","author":"Braun","year":"2018","journal-title":"Brain Behav Immun."},{"key":"B112","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/cercor\/bht202","article-title":"CB 1 and CB 2 cannabinoid receptor antagonists prevent minocycline-induced neuroprotection following traumatic brain injury in mice","volume":"25","author":"Belen Lopez-Rodriguez","year":"2013","journal-title":"Cereb Cortex."},{"key":"B113","doi-asserted-by":"publisher","first-page":"3454","DOI":"10.3390\/cells10123454","article-title":"The novel monoacylglycerol lipase inhibitor MJN110 suppresses neuroinflammation, normalizes synaptic composition and improves behavioral performance in the repetitive traumatic brain injury mouse model","volume":"10","author":"Selvaraj","year":"2021","journal-title":"Cells."},{"key":"B114","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/jcbfm.2014.216","article-title":"Inhibition of monoacylglycerol lipase prevents chronic traumatic encephalopathy-like neuropathology in a mouse model of repetitive mild closed head injury","volume":"35","author":"Zhang","year":"2015","journal-title":"J Cereb Blood Flow Metab."},{"key":"B115","doi-asserted-by":"publisher","first-page":"18150","DOI":"10.1073\/pnas.1113444108","article-title":"The major central endocannabinoid directly acts at GABAA receptors","volume":"108","author":"Sigel","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"B116","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.neuron.2011.12.012","article-title":"Extrasynaptic GABAA receptors: their function in the CNS and implications for disease","volume":"73","author":"Brickley","year":"2012","journal-title":"Neuron."},{"key":"B117","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1476-5381.2010.00870.x","article-title":"Regional enhancement of cannabinoid CB1 receptor desensitization in female adolescent rats following repeated \u03949-tetrahydrocannabinol exposure","volume":"161","author":"Burston","year":"2010","journal-title":"Br J Pharmacol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.tips.2004.04.005","article-title":"Signaling pathways involved in the development of cannabinoid tolerance","volume":"25","author":"Martin","year":"2004","journal-title":"Trends Pharmacol Sci."},{"key":"B119","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3389\/fphar.2017.00259","article-title":"Inverted U-shaped dose-response curve of the anxiolytic effect of cannabidiol during public speaking in real life","volume":"8","author":"Zuardi","year":"2017","journal-title":"Front Pharmacol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"11229","DOI":"10.1073\/pnas.1711351114","article-title":"Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome","volume":"114","author":"Kaplan","year":"2017","journal-title":"Proc Natl Acad Sci USA."},{"key":"B121","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.bpsgos.2021.06.014","article-title":"Cannabidiol produces distinct U-shaped dose-response effects on cocaine-induced conditioned place preference and associated recruitment of prelimbic neurons in male rats","volume":"2","author":"Nedelescu","year":"2022","journal-title":"Biol psychiatry Glob open Sci."},{"key":"B122","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1056\/NEJMoa1611618","article-title":"Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome","volume":"376","author":"Devinsky","year":"2017","journal-title":"N Engl J Med."},{"key":"B123","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.3389\/fphar.2018.01365","article-title":"A systematic review on the pharmacokinetics of cannabidiol in humans","volume":"9","author":"Millar","year":"2018","journal-title":"Front Pharmacol"},{"key":"B124","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/35097089","article-title":"An endogenous cannabinoid (2-AG) is neuroprotective after brain injury","volume":"413","author":"Panikashvili","year":"2001","journal-title":"Nature."},{"key":"B125","doi-asserted-by":"publisher","first-page":"8711","DOI":"10.1074\/jbc.M114.618447","article-title":"Fatty acid-binding proteins (FABPs) are intracellular carriers for \u03949-tetrahydrocannabinol (THC) and cannabidiol (CBD)","volume":"290","author":"Elmes","year":"2015","journal-title":"J Biol Chem."},{"key":"B126","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/j.1476-5381.2010.01063.x","article-title":"Non-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action","volume":"162","author":"Maione","year":"2011","journal-title":"Br J Pharmacol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/bph.12944","article-title":"Are cannabidiol and \u03949-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review","volume":"172","author":"McPartland","year":"2015","journal-title":"Br J Pharmacol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"744","DOI":"10.3389\/fphar.2017.00744","article-title":"Binding and signaling studies disclose a potential allosteric site for cannabidiol in cannabinoid CB 2 receptors","volume":"8","author":"Mart\u00ednez-Pinilla","year":"2017","journal-title":"Front Pharmacol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.neuroscience.2014.12.051","article-title":"Cannabidiol increases survival and promotes rescue of cognitive function in a murine model of cerebral malaria","volume":"289","author":"Campos","year":"2015","journal-title":"Neuroscience."},{"key":"B130","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1111\/j.1476-5381.2011.01343.x","article-title":"Endocannabinoids and traumatic brain injury","volume":"163","author":"Shohami","year":"2011","journal-title":"Br J Pharmacol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"8268","DOI":"10.1073\/pnas.95.14.8268","article-title":"Cannabidiol and (\u2013)\u03949-tetrahydrocannabinol are neuroprotective antioxidants","volume":"95","author":"Hampson","year":"1998","journal-title":"Proc Natl Acad Sci USA."},{"key":"B132","doi-asserted-by":"publisher","first-page":"5354","DOI":"10.3390\/molecules26175354","article-title":"Contribution of the adenosine 2A receptor to behavioral effects of tetrahydrocannabinol, cannabidiol and PECS-101","volume":"26","author":"Stollenwerk","year":"2021","journal-title":"Molecules."},{"key":"B133","doi-asserted-by":"publisher","first-page":"5382","DOI":"10.1007\/s12035-018-1456-3","article-title":"Adenosine A2A-cannabinoid CB1 receptor heteromers in the hippocampus: cannabidiol blunts \u03b49-tetrahydrocannabinol-induced cognitive impairment","volume":"56","author":"Aso","year":"2019","journal-title":"Mol Neurobiol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"91","DOI":"10.4103\/sni.sni_45_18","article-title":"Review of the neurological benefits of phytocannabinoids","volume":"9","author":"Maroon","year":"2018","journal-title":"Surg Neurol Int."},{"key":"B135","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S1474-4422(02)00164-3","article-title":"Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury?","volume":"1","author":"Ikonomidou","year":"2002","journal-title":"Lancet Neurol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0300-483X(86)90116-2","article-title":"The effects of dietary butylated hydroxytoluene on liver and colon tumor development in mice","volume":"38","author":"Lindenschmidt","year":"1986","journal-title":"Toxicology."},{"key":"B137","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.phrs.2017.02.022","article-title":"The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABAA a receptors","volume":"119","author":"Bakas","year":"2017","journal-title":"Pharmacol Res."},{"key":"B138","first-page":"2616","article-title":"The potential roles of dopamine in traumatic brain injury: a preclinical and clinical update","volume":"11","author":"Lan","year":"2019","journal-title":"Am J Transl Res."},{"key":"B139","doi-asserted-by":"publisher","first-page":"335","DOI":"10.9740\/mhc.2020.11.335","article-title":"Traumatic brain injury and mood disorders","volume":"10","author":"Robert","year":"2020","journal-title":"Ment Heal Clin."},{"key":"B140","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.neubiorev.2009.03.011","article-title":"Persistent cognitive dysfunction after traumatic brain injury: a dopamine hypothesis","volume":"33","author":"Bales","year":"2009","journal-title":"Neurosci Biobehav Rev."},{"key":"B141","doi-asserted-by":"publisher","first-page":"e00682","DOI":"10.1002\/prp2.682","article-title":"Diversity of molecular targets and signaling pathways for CBD","volume":"8","author":"De Almeida","year":"2020","journal-title":"Pharmacol Res Perspect."},{"key":"B142","doi-asserted-by":"publisher","first-page":"e920","DOI":"10.1038\/tp.2016.195","article-title":"Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose","volume":"6","author":"Seeman","year":"2016","journal-title":"Transl Psychiatry."},{"key":"B143","first-page":"63","article-title":"Effects of cannabinoids on catecholamine uptake and release in hypothalamic and striatal synaptosomes","volume":"214","author":"Poddar","year":"1980","journal-title":"J Pharmacol Exp Ther."},{"key":"B144","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1111\/j.1476-5381.2011.01278.x","article-title":"Symptom-relieving and neuroprotective effects of the phytocannabinoid \u03949-THCV in animal models of Parkinson's disease","volume":"163","author":"Garc\u00eda","year":"2011","journal-title":"Br J Pharmacol."},{"key":"B145","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3389\/fphar.2018.00482","article-title":"Cannabidiol as a promising strategy to treat and prevent movement disorders?","volume":"9","author":"Peres","year":"2018","journal-title":"Front Pharmacol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.3389\/fpls.2018.01969","article-title":"The case for the entourage effect and conventional breeding of clinical cannabis: no \u201cstrain,\u201d no gain","volume":"9","author":"Russo","year":"2019","journal-title":"Front Plant Sci."},{"key":"B147","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s11064-005-6978-1","article-title":"Agonistic properties of cannabidiol at 5-HT1a receptors","volume":"30","author":"Russo","year":"2005","journal-title":"Neurochem Res."},{"key":"B148","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1097\/j.pain.0000000000001386","article-title":"Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain","volume":"160","author":"De Gregorio","year":"2019","journal-title":"Pain."},{"key":"B149","doi-asserted-by":"publisher","first-page":"611278","DOI":"10.3389\/fnbeh.2020.611278","article-title":"Cannabidiol acts at 5-HT1A receptors in the human brain: relevance for treating temporal lobe epilepsy","volume":"14","author":"Mart\u00ednez-Aguirre","year":"2020","journal-title":"Front Behav Neurosci."},{"key":"B150","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.neuropharm.2015.12.017","article-title":"Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT\/glutamate neurotransmission: role of 5-HT1A receptors","volume":"103","author":"Linge","year":"2016","journal-title":"Neuropharmacology."},{"key":"B151","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00213-008-1168-x","article-title":"Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats","volume":"199","author":"Campos","year":"2008","journal-title":"Psychopharmacology."},{"key":"B152","doi-asserted-by":"publisher","first-page":"7895","DOI":"10.1073\/pnas.0511232103","article-title":"Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression","volume":"103","author":"Carrier","year":"2006","journal-title":"Proc Natl Acad Sci USA."},{"key":"B153","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3390\/brainsci7080093","article-title":"Selective serotonin reuptake inhibitors for treating neurocognitive and neuropsychiatric disorders following traumatic brain injury: an evaluation of current evidence","volume":"7","author":"Yue","year":"2017","journal-title":"Brain Sci."},{"key":"B154","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.neuropharm.2013.03.027","article-title":"Mechanisms of cannabidiol neuroprotection in hypoxic\u2013ischemic newborn pigs: role of 5HT1A and CB2 receptors","volume":"71","author":"Pazos","year":"2013","journal-title":"Neuropharmacology."},{"key":"B155","doi-asserted-by":"publisher","first-page":"CNC94","DOI":"10.2217\/cnc-2021-0001","article-title":"Altered biphasic serotonin discharge hypothesis in mild traumatic brain injury","volume":"6","author":"Shinoda","year":"2021","journal-title":"Concussion."},{"key":"B156","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1038\/sj.bjp.0707460","article-title":"The orphan receptor GPR55 is a novel cannabinoid receptor","volume":"152","author":"Ryberg","year":"2007","journal-title":"Br J Pharmacol."},{"key":"B157","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1093\/toxsci\/kfab046","article-title":"Transcriptomic changes and the roles of cannabinoid receptors and PPAR\u03b3 in developmental toxicities following exposure to \u03b49-tetrahydrocannabinol and cannabidiol","volume":"99","author":"Pandelides","year":"2021","journal-title":"Toxicol Sci"},{"key":"B158","doi-asserted-by":"publisher","first-page":"9773","DOI":"10.3390\/ijms22189773","article-title":"Neuroprotective effects of cannabidiol but not \u03b49-tetrahydrocannabinol in rat hippocampal slices exposed to oxygen-glucose deprivation: studies with cannabis extracts and selected cannabinoids","volume":"22","author":"Landucci","year":"2021","journal-title":"Int J Mol Sci."},{"key":"B159","doi-asserted-by":"publisher","first-page":"3713","DOI":"10.1172\/JCI64628","article-title":"Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes","volume":"124","author":"Ol\u00e1h","year":"2014","journal-title":"J Clin Invest."},{"key":"B160","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ebiom.2017.01.003","article-title":"Targeting cutaneous cannabinoid signaling in inflammation - a \u201chigh\u201d-way to heal?","volume":"16","author":"Ol\u00e1h","year":"2017","journal-title":"EBioMedicine."},{"key":"B161","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/sj.bjp.0705920","article-title":"Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation","volume":"143","author":"Costa","year":"2004","journal-title":"Br J Pharmacol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.2147\/JPR.S258433","article-title":"CBD effects on TRPV1 signaling pathways in cultured drg neurons","volume":"13","author":"Anand","year":"2020","journal-title":"J Pain Res."},{"key":"B163","doi-asserted-by":"publisher","first-page":"3908","DOI":"10.1111\/bph.12746","article-title":"Activation of GPR18 by cannabinoid compounds: a tale of biased agonism","volume":"171","author":"Console-Bram","year":"2014","journal-title":"J Pharmacol."},{"key":"B164","doi-asserted-by":"publisher","first-page":"105128","DOI":"10.1016\/j.phrs.2020.105128","article-title":"Cannabidiol inhibits febrile seizure by modulating AMPA receptor kinetics through its interaction with the N-terminal domain of GluA1\/GluA2","volume":"161","author":"Yu","year":"2020","journal-title":"Pharmacol Res."},{"key":"B165","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1177\/0269881119858306","article-title":"The effect of cannabidiol (CBD) on low-frequency activity and functional connectivity in the brain of adults with and without autism spectrum disorder (ASD)","volume":"33","author":"Pretzsch","year":"2019","journal-title":"J Psychopharmacol"},{"key":"B166","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41398-019-0654-8","article-title":"Effects of cannabidiol on brain excitation and inhibition systems; a randomised placebo-controlled single dose trial during magnetic resonance spectroscopy in adults with and without autism spectrum disorder","volume":"9","author":"Pretzsch","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"B167","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1089\/neu.2010.1579","article-title":"Neurogenesis in adult human brain after traumatic brain injury","volume":"30","author":"Zheng","year":"2013","journal-title":"J Neurotrauma."},{"key":"B168","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/jnr.20724","article-title":"Temporally specific proliferation events are induced in the hippocampus following acute focal injury","volume":"83","author":"Ernst","year":"2005","journal-title":"J Neurosci Res."},{"key":"B169","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.3389\/fnins.2018.01014","article-title":"Impact of traumatic brain injury on neurogenesis","volume":"12","author":"Xu","year":"2019","journal-title":"Front Neurosci."},{"key":"B170","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1478-811X-8-12","article-title":"Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis","volume":"8","author":"Wolf","year":"2010","journal-title":"Cell Commun Signal."},{"key":"B171","doi-asserted-by":"publisher","first-page":"28668","DOI":"10.1371\/journal.pone.0028668","article-title":"Cannabidiol reduces ab-induced neuroinflammation and promotes hippocampal neurogenesis through PPARc involvement","volume":"6","author":"Esposito","year":"2011","journal-title":"PLoS ONE."},{"key":"B172","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.brainres.2008.09.074","article-title":"PPARgamma agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms","volume":"1244","author":"Yi","year":"2008","journal-title":"Brain Res."},{"key":"B173","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3389\/fnbeh.2020.00109","article-title":"The pro-neurogenic effects of cannabidiol and its potential therapeutic implications in psychiatric disorders","volume":"14","author":"Luj\u00e1n","year":"2020","journal-title":"Front Behav Neurosci."},{"key":"B174","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.pnpbp.2015.06.017","article-title":"Influence of single and repeated cannabidiol administration on emotional behavior and markers of cell proliferation and neurogenesis in non-stressed mice","volume":"64","author":"Schiavon","year":"2016","journal-title":"Prog Neuro-Psychopharmacology Biol Psychiatry."},{"key":"B175","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1089\/can.2017.0047","article-title":"Prolonged cannabidiol treatment effects on hippocampal subfield volumes in current cannabis users","volume":"3","author":"Beale","year":"2018","journal-title":"Cannabis Cannabinoid Res."},{"key":"B176","first-page":"14","article-title":"Microglia: the brain's first responders","author":"Bilbo","year":"2017","journal-title":"Cerebrum Dana Forum Brain Sci."},{"key":"B177","doi-asserted-by":"publisher","first-page":"964","DOI":"10.3389\/fneur.2018.00964","article-title":"Early microglial activation following closed-head concussive injury is dominated by pro-inflammatory M-1 type","volume":"9","author":"Madathil","year":"2018","journal-title":"Front Neurol."},{"key":"B178","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.neuroscience.2012.08.058","article-title":"Morphological and genetic activation of microglia after diffuse traumatic brain injury in the rat","volume":"225","author":"Cao","year":"2012","journal-title":"Neuroscience."},{"key":"B179","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3389\/fncel.2012.00058","article-title":"Understanding the neuroinflammatory response following concussion to develop treatment strategies","volume":"6","author":"Patterson","year":"2012","journal-title":"Front Cell Neurosci."},{"key":"B180","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.expneurol.2015.08.018","article-title":"Microglia in the TBI brain: the good, the bad, and the dysregulated","volume":"275","author":"Loane","year":"2016","journal-title":"Exp Neurol."},{"key":"B181","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.expneurol.2012.09.012","article-title":"Moderate traumatic brain injury promotes neural precursor proliferation without increasing neurogenesis in the adult hippocampus","volume":"239","author":"Gao","year":"2013","journal-title":"Exp Neurol."},{"key":"B182","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1074\/jbc.M307657200","article-title":"NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia","volume":"279","author":"Qin","year":"2004","journal-title":"J Biol Chem."},{"key":"B183","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1089\/can.2020.0109","article-title":"Cannabidiol-Driven alterations to inflammatory protein landscape of lipopolysaccharide-activated macrophages in vitro may be mediated by autophagy and oxidative stress","volume":"6","author":"Yeisley","year":"2021","journal-title":"Cannabis Cannabinoid Res."},{"key":"B184","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/S0002-9440(10)63698-X","article-title":"An angiogenic switch in macrophages involving synergy between toll-like receptors 2, 4, 7, and 9 and adenosine A2A receptors","volume":"163","author":"Pinhal-Enfield","year":"2003","journal-title":"Am J Pathol."},{"key":"B185","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.nbd.2013.06.016","article-title":"Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: a role for A2A receptors","volume":"59","author":"Mecha","year":"2013","journal-title":"Neurobiol Dis."},{"key":"B186","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1177\/1099800411431823","article-title":"The role of free radicals in traumatic brain injury","volume":"15","author":"O'connell","year":"2013","journal-title":"Biol Res Nurs."},{"key":"B187","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1124\/pr.54.2.271","article-title":"Antioxidant therapy in acute central nervous system injury: current state","volume":"54","author":"Gilgun-Sherki","year":"2002","journal-title":"Pharmacol Rev."},{"key":"B188","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1742-2094-7-41","article-title":"Gp91phox (NOX2) in classically activated microglia exacerbates traumatic brain injury","volume":"7","author":"Dohi","year":"2010","journal-title":"J Neuroinflammation."},{"key":"B189","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/antiox9010021","article-title":"Antioxidative and anti-inflammatory properties of cannabidiol","volume":"9","author":"Atalay","year":"2020","journal-title":"Antioxidants."},{"key":"B190","doi-asserted-by":"publisher","first-page":"383","DOI":"10.5935\/0103-507X.20150064","article-title":"Avalia\u00e7\u00e3o do papel do sistema canabidiol em um modelo de les\u00e3o renal por isquemia\/reperfus\u00e3o em animais","volume":"27","author":"Soares","year":"2015","journal-title":"Rev Bras Ter Intensiva."},{"key":"B191","doi-asserted-by":"publisher","first-page":"12663","DOI":"10.3390\/molecules181012663","article-title":"molecules understanding the molecular aspects of tetrahydrocannabinol and cannabidiol as antioxidants","volume":"18","author":"Borges","year":"2013","journal-title":"Molecules."},{"key":"B192","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1124\/jpet.105.085779","article-title":"Comparison of cannabidiol, antioxidants, and diuretics in reversing binge ethanol-induced neurotoxicity","volume":"314","author":"Hamelink","year":"2005","journal-title":"J Pharmacol Exp Ther."},{"key":"B193","doi-asserted-by":"publisher","first-page":"H610","DOI":"10.1152\/ajpheart.00236.2007","article-title":"Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption","volume":"293","author":"Rajesh","year":"2007","journal-title":"Am J Physiol."},{"key":"B194","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1124\/jpet.108.147181","article-title":"Cannabidiol attenuates cisplatin-induced nephrotoxicity by decreasing oxidative\/nitrosative stress, inflammation, and cell death","volume":"328","author":"Pan","year":"2009","journal-title":"J Pharmacol Exp Ther."},{"key":"B195","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1089\/neu.2015.3949","article-title":"Circulating brain-derived neurotrophic factor has diagnostic and prognostic value in traumatic brain injury","volume":"33","author":"Korley","year":"2016","journal-title":"J Neurotrauma."},{"key":"B196","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1007\/s00134-003-1852-6","article-title":"Correlation between neurotrophic factor expression and outcome of children with severe traumatic brain injury","volume":"29","author":"Chiaretti","year":"2003","journal-title":"Intensive Care Med."},{"key":"B197","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1146\/annurev.neuro.24.1.677","article-title":"Neurotrophins: roles in neuronal development and function","volume":"24","author":"Huang","year":"2007","journal-title":"Annu Rev Neurosci."},{"key":"B198","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/dneu.20774","article-title":"Brain-Derived neurotrophic factor and the development of structural neuronal connectivity","volume":"70","author":"Cohen-Cory","year":"2010","journal-title":"Inc Dev Neurobiol."},{"key":"B199","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/FBP.0b013e32833d8bc9","article-title":"Brain-derived neurotrophic factor in traumatic brain injury, post-traumatic stress disorder, and their comorbid conditions: role in pathogenesis and treatment","volume":"21","author":"Kaplan","year":"2010","journal-title":"Behav Pharmacol."},{"key":"B200","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1146\/annurev.neuro.24.1.1217","article-title":"Nerve growth factor signaling, neuroprotection, and neural repair","volume":"24","author":"Sofroniew","year":"2001","journal-title":"Annu Rev Neurosci."},{"key":"B201","doi-asserted-by":"publisher","first-page":"5900","DOI":"10.1523\/JNEUROSCI.2343-16.2017","article-title":"Activation of PERK elicits memory impairment through inactivation of CREB and downregulation of PSD95 after traumatic brain injury","volume":"37","author":"Sen","year":"2017","journal-title":"J Neurosci."},{"key":"B202","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1007\/s12035-018-1143-4","article-title":"Cannabidiol induces rapid and sustained antidepressant-like effects through increased BDNF signaling and synaptogenesis in the prefrontal cortex","volume":"56","author":"Sales","year":"2019","journal-title":"Mol Neurobiol."},{"key":"B203","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/rheumatology\/keaa252","article-title":"Cognitive dysfunction and serum levels of brain-derived neurotrophic factor (BDNF) in primary anti-phospholipid syndrome (PAPS)","volume":"60","author":"Rosa","year":"2021","journal-title":"Rheumatology."},{"key":"B204","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/ana.410090506","article-title":"Mood change following left hemispheric brain injury","volume":"9","author":"Robinson","year":"1981","journal-title":"Ann Neurol."},{"key":"B205","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/neu.2015.3905","article-title":"Brain networks subserving emotion regulation and adaptation after mild traumatic brain injury","volume":"33","author":"Van Der Horn","year":"2015","journal-title":"J Neurotrauma."},{"key":"B206","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.biopsych.2006.07.024","article-title":"Hippocampal volume and mood disorders after traumatic brain injury","volume":"62","author":"Jorge","year":"2007","journal-title":"Biol Psychiatry."},{"key":"B207","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1601-5215.2011.00579.x","article-title":"Administration of cannabidiol and imipramine induces antidepressant-like effects in the forced swimming test and increases brain-derived neurotrophic factor levels in the rat amygdala","volume":"23","author":"R\u00e9us","year":"2011","journal-title":"Acta Neuropsychiatrica."},{"key":"B208","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.pnpbp.2016.11.005","article-title":"Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia","volume":"75","author":"Mori","year":"2017","journal-title":"Prog Neuro Psychopharmacol Biol Psychiatry."},{"key":"B209","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.arcmed.2014.11.006","article-title":"The blood-brain barrier as a target in traumatic brain injury treatment","volume":"45","author":"Thal","year":"2014","journal-title":"Arch Med Res."},{"key":"B210","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s00011-013-0677-1","article-title":"Biphasic activation of nuclear factor kappa B and expression of p65 and c-Rel after traumatic brain injury in rats","volume":"63","author":"Hu","year":"2014","journal-title":"Inflamm Res."},{"key":"B211","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.nbd.2018.07.030","article-title":"A differentiating neural stem cell-derived astrocytic population mitigates the inflammatory effects of TNF-\u03b1 and IL-6 in an iPSC-based blood-brain barrier model","volume":"119","author":"Mantle","year":"2018","journal-title":"Neurobiol Dis."},{"key":"B212","doi-asserted-by":"publisher","first-page":"10588","DOI":"10.1523\/JNEUROSCI.2323-09.2009","article-title":"Neurobiology of disease astrocytic dysfunction in epileptogenesis: consequence of altered potassium and glutamate homeostasis?","volume":"29","author":"David","year":"2009","journal-title":"J Neurosci"},{"key":"B213","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1089\/neu.1995.12.53","article-title":"Altered immunoexpression of microglia and macrophages after mild head injury","volume":"12","author":"Aihara","year":"1995","journal-title":"J Neurotrauma."},{"key":"B214","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1007\/3-211-30714-1_91","article-title":"Inflammation and brain edema: new insights into the role of chemokines and their receptors","volume":"96","author":"Stamatovic","year":"2006","journal-title":"Acta Neurochir."},{"key":"B215","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/labinvest.2015.70","article-title":"TGF\u03b21 exacerbates blood-brain barrier permeability in a mouse model of hepatic encephalopathy via upregulation of MMP9 and downregulation of claudin-5","volume":"95","author":"McMillin","year":"2015","journal-title":"Lab Invest."},{"key":"B216","doi-asserted-by":"publisher","first-page":"e101815","DOI":"10.1371\/journal.pone.0101815","article-title":"Downregulation of blood-brain barrier phenotype by proinflammatory cytokines involves NADPH oxidase-dependent ROS generation: consequences for interendothelial adherens and tight junctions","volume":"9","author":"Rochfort","year":"2014","journal-title":"PLoS ONE."},{"key":"B217","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/bph.13368","article-title":"Cannabidiol protects an in vitro model of the blood\u2013brain barrier from oxygen-glucose deprivation via PPAR\u03b3 and 5-HT1A receptors","volume":"173","author":"Hind","year":"2016","journal-title":"Br J Pharmacol."},{"key":"B218","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1016\/j.jid.2017.05.035","article-title":"Cannabinoid reduces inflammatory cytokines tumor necrosis factor alpha and type I interferons in dermatomyositis in vitro","volume":"137","author":"Robinson","year":"2017","journal-title":"J Invest Dermatol."},{"key":"B219","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1111\/bph.13497","article-title":"An update on PPAR activation by cannabinoids","volume":"173","author":"O'Sullivan","year":"2016","journal-title":"Br J Pharmacol."},{"key":"B220","doi-asserted-by":"publisher","first-page":"236","DOI":"10.4103\/2231-4040.90879","article-title":"The peroxisome proliferator-activated receptor: a family of nuclear receptors role in various diseases","volume":"2","author":"Tyagi","year":"2011","journal-title":"J Adv Pharm Technol Res."},{"key":"B221","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.bbrc.2017.03.106","article-title":"Activation of PPAR\u03b3 inhibits pro-inflammatory cytokines production by upregulation of miR-124 in vitro and in vivo","volume":"486","author":"Wang","year":"2017","journal-title":"Biochem Biophys Res Commun."},{"key":"B222","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3109\/10641969909068668","article-title":"The consequences of traumatic brain injury on cerebral blood flow and autoregulation: a review","volume":"21","author":"Golding","year":"2009","journal-title":"Clin Exp Hypertens."},{"key":"B223","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/BF01405899","article-title":"The relation between intracrainal pressure, mean arterial pressure and cerebral blood flow in patients with severe head injury","volume":"32","author":"Gobiet","year":"1975","journal-title":"Acta Neurochir."},{"key":"B224","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1097\/00000658-197710000-00002","article-title":"Correlation of cerebral blood flow with outcome in head injured patients","volume":"186","author":"Langfitt","year":"1977","journal-title":"Ann Surg."},{"key":"B225","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1475-097X.2010.00990.x","article-title":"Cerebrovascular pathophysiology following mild traumatic brain injury","volume":"31","author":"Len","year":"2011","journal-title":"Clin Physiol Funct Imaging."},{"key":"B226","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3109\/10641963.2013.827701","article-title":"Depression and anxiety are associated with abnormal nocturnal blood pressure fall in hypertensive patients","volume":"36","author":"Sunbul","year":"2014","journal-title":"Clin Exp Hypertens."},{"key":"B227","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1136\/jnnp.55.7.594","article-title":"Cerebral blood flow, arteriovenous oxygen difference, and outcome in head injured patients","volume":"55","author":"Robertson","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B228","doi-asserted-by":"publisher","first-page":"633","DOI":"10.3171\/jns.1997.86.4.0633","article-title":"Cerebral blood flow as a predictor of outcome following traumatic brain injury","volume":"86","author":"Kelly","year":"1997","journal-title":"J Neurosurg."},{"key":"B229","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3171\/jns.1997.86.3.0425","article-title":"Cerebral autoregulation following minor head injury","volume":"86","author":"J\u00fcnger","year":"1997","journal-title":"J Neurosurg."},{"key":"B230","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3171\/jns.1998.89.4.0507","article-title":"Factors affecting excitatory amino acid release following severe human head injury","volume":"89","author":"Bullock","year":"1998","journal-title":"J Neurosurg."},{"key":"B231","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/jcbfm.1984.21","article-title":"Cerebrovascular smooth muscle reactivity: a critical appraisal of in vitro and in situ techniques","volume":"4","author":"McCulloch","year":"1984","journal-title":"J Cereb Blood Flow Metab."},{"key":"B232","doi-asserted-by":"crossref","DOI":"10.3109\/02688698708999633","article-title":"Cerebral Arterial Vasospasm Following Severe Head Injury: A Transcranial Doppler Study","author":"Compton","year":""},{"key":"B233","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3171\/jns.1986.64.5.0803","article-title":"Superoxide production in experimental brain injury","volume":"64","author":"Kontos","year":"1986","journal-title":"J Neurosurg."},{"key":"B234","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1111\/j.1471-4159.2007.04565.x","article-title":"Delayed treatment with cannabidiol has a cerebroprotective action via a cannabinoid receptor-independent myeloperoxidase-inhibiting mechanism","volume":"102","author":"Hayakawa","year":"2007","journal-title":"J Neurochem."},{"key":"B235","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.1476-5381.2008.00046.x","article-title":"5-HT 1A receptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats","volume":"156","author":"Resstel","year":"2009","journal-title":"Br J Pharmacol"},{"key":"B236","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1177\/0269881120936419","article-title":"The effects of acute cannabidiol on cerebral blood flow and its relationship to memory: an arterial spin labelling magnetic resonance imaging study","volume":"34","author":"Bloomfield","year":"2020","journal-title":"J Psychopharmacol."},{"key":"B237","doi-asserted-by":"publisher","first-page":"136141","DOI":"10.1016\/j.neulet.2021.136141","article-title":"Cannabidiol microinjection into the nucleus accumbens attenuated nociceptive behaviors in an animal model of tonic pain","volume":"762","author":"Razavi","year":"2021","journal-title":"Neurosci Lett."},{"key":"B238","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/0304-3959(92)90003-T","article-title":"The formalin test: an evaluation of the method","volume":"51","author":"Tj\u00f8lsen","year":"1992","journal-title":"Pain."},{"key":"B239","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.brainres.2019.03.014","article-title":"Cannabidiol attenuates mechanical allodynia in streptozotocin-induced diabetic rats via serotonergic system activation through 5-HT1A receptors","volume":"1715","author":"Jesus","year":"2019","journal-title":"Brain Res."},{"key":"B240","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.brainres.2012.06.023","article-title":"Blockade of D1\/D2 dopamine receptors within the nucleus accumbens attenuated the antinociceptive effect of cannabinoid receptor agonist in the basolateral amygdala","volume":"1471","author":"Haghparast","year":"2012","journal-title":"Brain Res."},{"key":"B241","doi-asserted-by":"publisher","first-page":"6682275","DOI":"10.1155\/2021\/6682275","article-title":"The distinct functions of dopaminergic receptors on pain modulation: a narrative review","volume":"2021","author":"Wang","year":"2021","journal-title":"Neural Plast."},{"key":"B242","doi-asserted-by":"publisher","first-page":"CNC49","DOI":"10.2217\/CNC-2017-0010","article-title":"Understanding the endocannabinoid system as a modulator of the trigeminal pain response to concussion","volume":"2","author":"Elliott","year":"2017","journal-title":"Concussion."},{"key":"B243","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1089\/neu.2015.4087","article-title":"Trigeminal pain molecules, allodynia, and photosensitivity are pharmacologically and genetically modulated in a model of traumatic brain injury","volume":"33","author":"Daiutolo","year":"2016","journal-title":"J Neurotrauma."},{"key":"B244","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3389\/fnbeh.2011.00064","article-title":"Sexually dimorphic effects of cannabinoid compounds on emotion and cognition","volume":"5","author":"Rubino","year":"2011","journal-title":"Front Behav Neurosci."},{"key":"B245","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.yfrne.2016.01.003","article-title":"Sex differences in cannabinoid-regulated biology: a focus on energy homeostasis","volume":"40","author":"Wagner","year":"2016","journal-title":"Front Neuroendocrinol."},{"key":"B246","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13293-021-00402-2","article-title":"Sex differences in the expression of the endocannabinoid system within V1M cortex and PAG of sprague dawley rats","volume":"12","author":"Levine","year":"2021","journal-title":"Biol Sex Differ."},{"key":"B247","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/npp.2017.140","article-title":"Sex-dependent effects of cannabis and cannabinoids: a translational perspective","volume":"43","author":"Cooper","year":"2018","journal-title":"Neuropsychopharmacology."},{"key":"B248","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1177\/0269881111408956","article-title":"The endocannabinoid system in critical neurodevelopmental periods: sex differences and neuropsychiatric implications","volume":"26","author":"Viveros","year":"2012","journal-title":"J Psychopharmacol."},{"key":"B249","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3389\/fneur.2014.00161","article-title":"Differential expression of brain cannabinoid receptors between repeatedly stressed males and females may play a role in age and gender-related difference in traumatic brain injury: implications from animal studies","volume":"5","author":"Xing","year":"2014","journal-title":"Front Neurol."},{"key":"B250","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1089\/can.2016.0034","article-title":"An update on safety and side effects of cannabidiol: a review of clinical data and relevant animal studies","volume":"2","author":"Iffland","year":"2017","journal-title":"Cannabis cannabinoid Res."},{"key":"B251","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2174\/157488611798280924","article-title":"Safety and side effects of cannabidiol, a cannabis sativa constituent","volume":"6","author":"Bergamaschi","year":"2011","journal-title":"Curr Drug Saf."},{"key":"B252","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s40263-018-0578-5","article-title":"A phase I, randomized, double-blind, placebo-controlled, single ascending dose, multiple dose, and food effect trial of the safety, tolerability and pharmacokinetics of highly purified cannabidiol in healthy subjects key points","volume":"32","author":"Taylor","year":"2018","journal-title":"CNS Drugs"},{"key":"B253","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1111\/epi.14477","article-title":"Long-term safety and treatment effects of cannabidiol in children and adults with treatment-resistant epilepsies: expanded access program results","volume":"59","author":"Szaflarski","year":"2018","journal-title":"Epilepsia."},{"key":"B254","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1056\/NEJMoa1714631","article-title":"Effect of cannabidiol on drop seizures in the lennox\u2013gastaut syndrome","volume":"378","author":"Devinsky","year":"2018","journal-title":"N Engl J Med."},{"key":"B255","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1038\/s41386-020-0667-2","article-title":"Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trials","volume":"45","author":"Chesney","year":"2020","journal-title":"Neuropsychopharmacology."},{"key":"B256","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1124\/dmd.121.000442","article-title":"Cannabinoid metabolites as inhibitors of major hepatic CYP450 enzymes, with implications for cannabis-drug interactions","volume":"49","author":"Nasrin","year":"2021","journal-title":"Drug Metab Dispos"},{"key":"B257","year":"","journal-title":"CANNabinoid Drug Interaction Review"},{"key":"B258","year":""},{"key":"B259","year":""},{"key":"B260","year":"2019"},{"key":"B261","year":""},{"key":"B262","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2019.07.007","article-title":"Traumatic brain injury (TBI) in collision sports: possible mechanisms of transformation into chronic traumatic encephalopathy (CTE)","author":"VanItallie","year":"2019","journal-title":"Metabolism."},{"key":"B263","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1001\/jama.2017.8334","article-title":"Clinicopathological evaluation of chronic traumatic encephalopathy in players of american football","volume":"318","author":"Mez","year":"2017","journal-title":"JAMA."},{"key":"B264","doi-asserted-by":"publisher","first-page":"980","DOI":"10.3389\/fneur.2019.00980","article-title":"Tau pathology in chronic traumatic encephalopathy and Alzheimer's disease: similarities and differences","volume":"10","author":"Katsumoto","year":"2019","journal-title":"Front Neurol."},{"key":"B265","doi-asserted-by":"publisher","first-page":"3521","DOI":"10.3390\/cells10123521","article-title":"Cannabidiol inhibits tau aggregation in vitro","volume":"10","author":"Alali","year":"2021","journal-title":"Cells."},{"key":"B266","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s00109-005-0025-1","article-title":"The marijuana component cannabidiol inhibits beta-amyloid-induced tau protein hyperphosphorylation through Wnt\/beta-catenin pathway rescue in PC12 cells","volume":"84","author":"Esposito","year":"2006","journal-title":"J Mol Med."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1087011\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T06:23:27Z","timestamp":1675319007000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1087011\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,2]]},"references-count":266,"alternative-id":["10.3389\/fneur.2023.1087011"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2023.1087011","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,2]]},"article-number":"1087011"}}